Navigation Links
Corporate Affairs Role in Internal and External Relationships Key to Organizational Success

CHAPEL HILL, N.C., Nov. 5, 2010 /PRNewswire/ -- Corporate Affairs – also called Public Affairs – sustains internal and external relationships that are key success drivers for organizations. In many organizations, Corporate/Public Affairs is home to functions such as Government Affairs, Corporate Communications and Patient Advocacy – groups that are essential to maintaining and enhancing interactions with important external and internal partners.

Recognizing the importance these subgroups of Corporate/Public Affairs play in overall organizational success, Best Practices, LLC has published a series of reports that identify key benchmarks around structure, resources and priorities for each of these important subgroups as well as one for Corporate Affairs overall.

Listed below are the different studies examining performance excellence in each of these key groups: 

  • Corporate Affairs Excellence: Optimizing Group Structure & Operations (PSM-251)
  • Government Affairs and Public Policy Excellence: Optimizing Group Structure & Operations (PSM-252)
  • Advocacy Excellence: Optimizing Group Structure & Operations (PSM-253)
  • Communications Excellence: Optimizing Group Structure & Operations (PSM-254)

To download complimentary study excerpts for any of these reports, go to:

Topics covered in each of these studies include:

- Group Structures and Drivers of Subgroup Evolution

- Staffing Benchmarks: Key Trends in Resourcing

- Funding Levels and Sources

- Group Services: Trends in Service Levels & Key Priorities

- Roles and Responsibilities: Trends in Alliances Management

Best Practices, LLC used both field surveys and interviews to complete these studies. The reports reflect the current state of efforts at best-in-class organizations such as Abbott, AstraZeneca, Amgen, Merck, Boehringer Ingelheim, Pfizer, Baxter, Lilly, Genentech, Novo Nordisk and others.


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit:

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
6. AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in ... (see Table 1-1 ). More than 3.7 billion people under the age of ... 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):